A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Asan Medical Center
Elsan
Carmel Medical Center
Henan Cancer Hospital
Assiut University
Qilu Pharmaceutical Co., Ltd.
Guangdong Provincial People's Hospital
Celtic Biotech Ltd
Akdeniz University
Taipei Medical University
Pamukkale University
Jiangsu Cancer Institute & Hospital
University of Medicine and Pharmacy at Ho Chi Minh City
Novatim Immune Therapeutics (Zhejiang) Co., Ltd.
CanWell Pharma Inc.
Ruijin Hospital
Istanbul University - Cerrahpasa
Beijing StarMab Biomed Technology Ltd
Washington University School of Medicine
Hospices Civils de Lyon
University Hospital, Linkoeping
Karolinska University Hospital
University of Oklahoma
Affiliated Hospital of North Sichuan Medical College
Tianjin Chasesun Pharmaceutical Co., LTD
BeBetter Med Inc
Ain Shams University
MaineHealth
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Masaryk University
West China Hospital
Imperial College London
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Centre Antoine Lacassagne
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Fujian Medical University
Second Affiliated Hospital of Soochow University
Peking Union Medical College Hospital
Cantonal Hospital of St. Gallen
Koç University
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Hanmi Pharmaceutical Company Limited
QureBio Ltd.
Sun Yat-sen University
University of Ulm
Immune Oncology Research Institute
Oregon Health and Science University
European Institute of Oncology
Cyprus University of Technology